SCHEMBL2387708

SCHEMBL2387708

O=C(c1ccc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1)N1CCC(c2cncc(F)c2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
ATM Q13315 1/20 0.52
NAMPT P43490 4/20 0.52
PROKR1 Q8TCW9 2/20 0.46
HSD11B1 P28845 1/20 0.45
KCNH2 Q12809 1/20 0.44
CYP3A4 P08684 1/20 0.43
SCN9A Q15858 1/20 0.43
EGLN1 Q9GZT9 1/20 0.42
GAA P10253 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SLC9A1 P19634 2/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR2B P41595 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2390843 0.89 PROKR1 (0.47) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2392580 0.87 LMNA (0.48) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2390000 0.86 NAMPT (0.61) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2387812 0.85 NAMPT (0.62) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2389787 0.81 NAMPT (0.61) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2391018 0.80 NAMPT (0.57) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL12255559 0.80 NAMPT (0.56) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2387816 0.80 NAMPT (0.56) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2388461 0.79 NAMPT (0.57) NPC1RAB9AATMNAMPTPROKR1
SCHEMBL2390969 0.78 NAMPT (0.59) NPC1RAB9AATMNAMPTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367679-B2 Biaryl carboxamides MERCK SHARP & DOHME CORP. (US) 2013-02-05 US claimed
US-20110230498-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. 2011-09-22 US claimed
EP-2375904-B1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME (US) 2014-05-28 EP disclosed
US-8367679-B2 Biaryl carboxamides MERCK SHARP & DOHME CORP. (US) 2013-02-05 US disclosed
US-20110230498-A1 BIARYL CARBOXAMIDES MERCK SHARP & DOHME CORP. 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230498-A1 BIARYL CARBOXAMIDES PAFAH1B3, PAFAH1B2, FAAH2 NPC1 561/4885RAB9A 2259/4885ATM 4704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.